imipramine has been researched along with Lung Diseases, Interstitial in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since pulmonary fibrosis is a recognized, if rare, complication of certain drug exposures, including antidepressants, betablockers, antibiotics, anticonvulsants, and nonsteroidal antiinflammatory drugs (NSAIDs), we tested the hypothesis that exposure to these drugs might contribute to the etiology of cryptogenic fibrosing alveolitis." | 1.30 | Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study. ( Britton, J; Cooper, M; Hubbard, R; Johnston, I; Smith, C; Venn, A, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hubbard, R | 1 |
| Venn, A | 1 |
| Smith, C | 1 |
| Cooper, M | 1 |
| Johnston, I | 1 |
| Britton, J | 1 |
1 other study available for imipramine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 1998 |